|
215
|
675
|
9cbjA |
Crystal structure of danio rerio histone deacetylase 10 in complex with p-aminopropyl phenylthioketone |
|
218
|
676
|
9cbiA |
Crystal structure of danio rerio histone deacetylase 10 in complex with p-aminoethyl phenylthioketone |
|
206
|
675
|
9cbhA |
Crystal structure of danio rerio histone deacetylase 10 in complex with p-aminomethyl phenylthioketone |
|
103
|
295
|
9c55A |
Crystal structure of human ptpn2 in complex with active site inhibitor |
|
217
|
676
|
9cbfA |
Crystal structure of danio rerio histone deacetylase 10 in complex with m-aminomethyl phenylthioketone |
|
143
|
357
|
9cbkA |
Crystal structure of danio rerio histone deacetylase 6 in complex with p-aminomethyl phenylthioketone |
|
212
|
676
|
9cbgA |
Crystal structure of danio rerio histone deacetylase 10 in complex with m-aminoethyl phenylthioketone |
|
94
|
279
|
9c56A |
Crystal structure of human ptpn2 in complex with allosteric inhibitor |
|
55
|
248
|
9azkA |
Macrocyclic inhibitors targeting the prime site of the fibrinolytic serine protease plasmin |
|
55
|
223
|
8xnjA |
Crystal structure of trypsin in-complex with arginine |
|
55
|
223
|
8xniA |
Crystal structure of trypsin in-complex with e-64 |
|
121
|
323
|
8wkfA |
Rational design of highly selective pde5 inhibitors for the treatment of idiopathic pulmonary fibrosis |
|
123
|
323
|
8wkgA |
Rational design of highly selective pde5 inhibitors for the treatment of idiopathic pulmonary fibrosis |
|
88
|
306
|
8w1tA |
Sars-cov-2 main protease bound to a non-covalent non-peptidic hts hit |
|
85
|
301
|
8w1uA |
Sars-cov-2 main protease bound to non-covalent lead molecule nz-804 |
|
85
|
249
|
8vauA |
Nicotinamide riboside and cd38: covalent inhibition and live-cell labeling |
|
20
|
92
|
8fvnA |
Pcsk9 in complex with an inhibitor |
|
20
|
92
|
8fvqA |
Pcsk9 in complex with an inhibitor |
|
21
|
92
|
8fvoA |
Pcsk9 in complex with an inhibitor |
|
139
|
529
|
8fvpB |
Pcsk9 in complex with an inhibitor |
|
23
|
92
|
8fvmA |
Pcsk9 in complex with an inhibitor |
|
141
|
529
|
8fvqB |
Pcsk9 in complex with an inhibitor |
|
141
|
529
|
8fvlB |
Pcsk9 in complex with an inhibitor |
|
140
|
529
|
8fvoB |
Pcsk9 in complex with an inhibitor |
|
137
|
529
|
8fvnB |
Pcsk9 in complex with an inhibitor |
|
0
|
5
|
8fvmC |
Pcsk9 in complex with an inhibitor |
|
138
|
529
|
8fpoB |
Pcsk9 in complex with an inhibitor |
|
21
|
92
|
8fpoA |
Pcsk9 in complex with an inhibitor |
|
21
|
92
|
8fpqA |
Pcsk9 in complex with an inhibitor |
|
140
|
530
|
8fpqB |
Pcsk9 in complex with an inhibitor |
|
20
|
92
|
8fvlA |
Pcsk9 in complex with an inhibitor |
|
0
|
6
|
8fvqL |
Pcsk9 in complex with an inhibitor |
|
0
|
7
|
8fvlL |
Pcsk9 in complex with an inhibitor |
|
20
|
92
|
8fvpA |
Pcsk9 in complex with an inhibitor |
|
0
|
13
|
8fpqL |
Pcsk9 in complex with an inhibitor |
|
142
|
530
|
8fvmB |
Pcsk9 in complex with an inhibitor |
|
91
|
360
|
8w10A |
Plasmodium vivax pmx-mk7602 inhibitor complex |
|
84
|
302
|
8udfA |
Crystal structure of sars-cov-2 3cl protease with inhibitor del_7 |
|
83
|
305
|
8ue0A |
Crystal structure of sars-cov-2 3cl protease with inhibitor 47 |
|
81
|
304
|
8uebA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 30 |
|
84
|
302
|
8uefA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 32 |
|
86
|
304
|
8uehA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 31 |
|
82
|
304
|
8uegA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 27 |
|
82
|
304
|
8udxA |
Crystal structure of sars-cov-2 3cl protease with c145 sulfinic acid in complex with inhibitor 17 |
|
87
|
306
|
8udmA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 16 |
|
82
|
302
|
8ueaA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 29 |
|
85
|
301
|
8udyA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 25 |
|
86
|
302
|
8udqA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 1 |
|
87
|
305
|
8udpA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 14 |
|
83
|
301
|
8udwA |
Crystal structure of sars-cov-2 3cl protease with inhibitor 2 |
